Stopping pandemics before they start: Lessons learned from SARS-CoV-2

Area of Science:

• Virology
• Immunology
• Pharmacology

Background:

• The COVID-19 pandemic caused over 5 million deaths by late 2021.
• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continues to evolve globally.
• Existing pandemic preparedness measures were challenged by the rapid spread and impact of SARS-CoV-2.

Purpose of the Study:

• To review the development of COVID-19 vaccines, antibody therapies, and antiviral drugs.
• To highlight the foundational role of long-term investment in basic science and technology.
• To recommend strategies for future pandemic preparedness and prevention.

Main Methods:

• Review of approved vaccines, antibody therapies, and antiviral drugs for COVID-19.
• Analysis of the scientific and technological advancements underpinning these medical countermeasures.
• Synthesis of lessons learned from the COVID-19 pandemic response.

Main Results:

• Approved COVID-19 vaccines, antibody therapies, and antiviral drugs represent significant scientific achievements.
• These medical advancements were enabled by decades of prior research and technological development.
• SARS-CoV-2 presented a critical test of global pandemic preparedness.

Conclusions:

• The success of COVID-19 countermeasures demonstrates the value of sustained investment in science.
• Urgent steps are needed to improve preparedness for future pandemics.
• Proactive measures can minimize the impact and potentially prevent future global health emergencies.